V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007739 | 300004909 | 1.73 | 66.05 | Not known (9) | null | 2015-08-26 | CISPLATIN + FLUOROURACIL | null | null | 300023558 | CISPLATIN + FLUOROURACIL |
| 300007740 | 300004910 | 1.71 | 54.6 | Palliative (P) | null | 2014-09-04 | Carboplatin + Paclitaxel (3 weekly) | 1 | N | 300023568 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 300007742 | 300004918 | 1.62 | 78.2 | Palliative (P) | null | 2016-03-17 | Oxaliplatin + Modified de Gramont | N | N | 300023703 | OXALIPLATIN + MDG |
| 300007743 | 300004920 | 1.65 | 61.15 | null | null | 2015-02-27 | Gemcitabine + Capecitabine | 02 | null | 300023705 | TRIAL |
| 300007744 | 300004920 | 1.74 | 73.4 | Palliative (P) | 2016-04-27 | 2016-05-04 | NIVOLUMAB | 02 | N | 300023705 | TEYSUNO |
| 300007745 | 300004926 | 1.53 | 0 | Palliative (P) | 2018-05-18 | 2018-06-07 | Fluorouricil + Folonic Acid (MdG) | N | N | 300023894 | OXALIPLATIN + MDG |
| 300007746 | 300004929 | 1.68 | null | Neo-adjuvant (N) | null | 2016-12-25 | ESPAC-4 TRIAL | null | null | 300023919 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300007747 | 300007046 | 1.71 | 82.2 | Neo-adjuvant (N) | 2017-03-12 | 2017-04-07 | Oxaliplatin + Modified de Gramont | Y | N | 300023934 | DOCETAXEL |
| 300007748 | 300004933 | null | 65.7 | Palliative (P) | 2015-06-16 | 2015-06-26 | Carboplatin + Etoposide IV 3 day | 01 | N | 300023938 | CARBOPLATIN |
| 300007749 | 300004936 | 1.71 | 47 | Adjuvant (A) | 2013-11-30 | 2013-12-03 | Cetuximab+Cisplatin+FU (> Cycle 2) | 2 | N | 300023954 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007750 | 300004938 | 1.56 | null | null | 2014-02-18 | 2014-02-28 | Carboplatin AUC 2 - 5 | N | Y | 300023964 | CARBOPLATIN |
| 300007751 | 300004941 | 1.6 | 67.5 | Palliative (P) | 2018-12-11 | 2018-12-25 | Capecitabine | N | Y | 300024034 | CARBOPLATIN |
| 300007752 | 300004945 | null | 55.4 | Neo-adjuvant (N) | 2014-01-31 | 2014-01-31 | CISPLATIN + FLUOROURACIL | N | N | 300024126 | CISPLATIN + FLUOROURACIL |
| 300007753 | 300004949 | null | 60.6 | Neo-adjuvant (N) | 2017-05-02 | 2017-05-20 | Oxaliplatin + Modified de Gramont | null | null | 300024212 | CISPLATIN + FLUOROURACIL |
| 300007754 | 300004950 | null | 40 | Adjuvant (A) | 2014-03-24 | 2014-04-01 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300024228 | CARBOPLATIN + PACLITAXEL |
| 300007756 | 300007057 | 1.76 | 55.4 | Palliative (P) | null | 2016-11-05 | Sunitinib | N | N | 300024289 | IRINOTECAN + MDG |
| 300007757 | 300004958 | 1.71 | 62.4 | Palliative (P) | 2014-04-26 | 2014-06-03 | Cisplatin | N | N | 300024303 | CAPECITABINE + OXALIPLATIN |
| 300007759 | 300004964 | null | 56.8 | Palliative (P) | 2018-04-27 | 2018-07-08 | CARBOPLATIN + GEMCITABINE | N | N | 300024361 | NILOTINIB |
| 300007760 | 300004969 | 1.73 | 78.4 | Palliative (P) | null | 2017-09-17 | Trial Unspecified | 02 | N | 300024396 | CARBOPLATIN |
| 300007761 | 300004971 | 1.81 | 86.3 | Palliative (P) | 2017-07-11 | 2017-08-07 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 300024413 | CAPECITABINE + OXALIPLATIN |
| 300007762 | 300007829 | 1.53 | 90 | Curative (C) | 2018-01-03 | 2018-01-03 | CARBOPLATIN + RT | N | Y | 300024471 | CARBOPLATIN + RT |
| 300007763 | 300007066 | 1.84 | null | Palliative (P) | 2015-06-08 | 2015-06-13 | Capecitabine | 02 | null | 300024529 | DE-ESCALATE TRIAL |
| 300007764 | 300004977 | 1.67 | 111 | null | 2017-04-15 | 2017-04-29 | Folfirinox | null | N | 300024567 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007765 | 300007071 | 1.63 | null | Palliative (P) | null | 2018-11-15 | Imatinib 400mg | N | N | 300024691 | PACLITAXEL |
| 300007766 | 300004983 | 1.7 | 63 | Curative (C) | 2014-11-29 | 2014-12-06 | Carboplatin AUC 6 - 10 | 2 | Y | 300024724 | CISPLATIN |
| 300007767 | 300004985 | 1.79 | 86 | Curative (C) | 2015-10-21 | 2015-11-15 | GEMCITABINE + NAB PACLITAXEL | 02 | null | 300024735 | TRIAL |
| 300007768 | 300007073 | 1.58 | 60.5 | Palliative (P) | null | 2013-12-18 | Dacarbazine | N | N | 300024775 | ESHAP R |
| 300007769 | 300007834 | 1.5 | 52.65 | Palliative (P) | 2017-10-12 | 2017-10-22 | Oxaliplatin + Modified de Gramont | 02 | N | 300024788 | IRINOTECAN + MDG |
| 300007770 | 300004991 | 0 | 60.6 | Palliative (P) | 2015-07-02 | 2016-03-07 | Capecitabine (14 days)+Carboplatin | 02 | N | 300024790 | CAPECITABINE |
| 300007771 | 300004993 | 0.88 | 81 | Not known (9) | 2013-09-24 | 2013-09-24 | Cisplatin +Fluorouracil (3 wk) | N | N | 300024793 | CARBOPLATIN |
| 300007772 | 300007075 | 1.78 | 71 | Palliative (P) | 2015-08-27 | 2016-01-06 | CAPECITABINE + GEMCITABINE | N | null | 300024838 | CARBOPLATIN + RT |
| 300007773 | 300007835 | 1.53 | 68.3 | null | 2015-07-03 | 2015-07-03 | Capecitabine | 2 | null | 300024858 | CAPECITABINE + STREPTOZOCIN |
| 300007774 | 300004999 | 1.66 | 78 | Palliative (P) | 2015-01-10 | 2015-06-09 | Oxaliplatin + Modified de Gramont | Y | null | 300024875 | OXALIPLATIN + MDG |
| 300007776 | 300005004 | 1.67 | 65.4 | Palliative (P) | 2016-07-15 | 2016-07-16 | CETUXIMAB | N | null | 300024887 | OXALIPLATIN + MDG |
| 300007777 | 300007079 | 1.67 | 60.3 | null | 2018-01-22 | 2018-01-28 | Trial Unspecified | N | null | 300024904 | PACLITAXEL |
| 300007778 | 300005010 | 1.66 | 44.6 | Curative (C) | 2014-11-25 | 2014-11-26 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | null | Y | 300024942 | TRIAL |
| 300007779 | 300005011 | 1.67 | 91.8 | Palliative (P) | 2016-08-27 | 2016-09-07 | Capecitabine | N | N | 300024966 | TRIAL |
| 300007780 | 300007838 | 1.67 | null | Adjuvant (A) | 2017-05-26 | 2017-09-12 | Trial Unspecified | N | null | 300024986 | ESPAC TRIAL |
| 300007781 | 300005014 | 1.7 | 63.15 | Curative (C) | 2017-06-13 | 2017-07-13 | Capecitabine + Cisplatin + RT | 02 | Y | 300025004 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007782 | 300007839 | 1.7 | null | Palliative (P) | 2018-01-27 | 2018-02-18 | Docetaxel 75mg/m2 (21 day) | N | N | 300025042 | IRINOTECAN + MDG |
| 300007783 | 300007086 | 1.58 | 74.4 | Curative (C) | 2015-12-14 | 2015-12-18 | Cetuximab + Radiotherapy Maint | 2 | Y | 300025053 | CAPECITABINE + RT |
| 300007784 | 300005019 | 1.73 | 60.2 | Disease modification (D) | 2015-09-19 | 2015-11-08 | Gemcitabine + Capecitabine | 02 | N | 300025082 | CETUXIMAB |
| 300007785 | 300007087 | 1.57 | 73.5 | Palliative (P) | 2014-07-25 | 2014-07-25 | Oxaliplatin + Modified de Gramont | 02 | N | 300025085 | CARBOPLATIN |
| 300007787 | 300005029 | 1.62 | 52.3 | Palliative (P) | 2017-05-16 | 2017-05-17 | Carboplatin AUC 2 - 5 | Y | null | 300025221 | CETUXIMAB |
| 300007789 | 300005034 | 1.76 | 60 | Palliative (P) | 2015-09-20 | 2015-09-26 | Oxaliplatin + Modified de Gramont | 2 | N | 300025245 | TRIAL |
| 300007790 | 300005036 | 1.61 | 74.5 | Curative (C) | 2017-02-23 | 2017-02-27 | Cetuximab 7 day (>Cycle 2) | N | Y | 300025258 | CAPECITABINE + CISPLATIN + RT |
| 300007792 | 300005041 | 1.87 | 53.5 | Palliative (P) | 2016-10-21 | 2017-02-12 | PEMBROLIZUMAB | N | null | 300025313 | DE-ESCALATE TRIAL |
| 300007793 | 300005044 | 1.57 | null | Curative (C) | 2014-05-02 | 2014-10-21 | Oxaliplatin + Modified de Gramont | N | null | 300025342 | CISPLATIN |
| 300007794 | 300007095 | 1.55 | 76.9 | Palliative (P) | 2016-01-25 | 2016-01-27 | PACLITAXEL | N | N | 300025345 | OXALIPLATIN + MDG |
| 300007795 | 300005047 | 1.46 | 40 | null | 2014-02-11 | 2017-10-25 | Cetuximab + Radiotherapy Maint | N | Y | 300025403 | CISPLATIN |